Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 15.53
-0.17 (-1.08%)
Aug 14, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 11.99 billion as of August 14, 2026. Its market cap has decreased by -7.07% in one year.
Market Cap
11.99B
Enterprise Value
10.50B
Revenue
6.13B
Ranking
n/a
PE Ratio
16.96
Stock Price
15.53
ChartMarket Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 11.99B, a decrease of -54.26%. That is a compound annual growth rate of -14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 11.99B | -12.58% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
| Aug 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 13.25B |
| Wedge Industrial | 13.10B |
| Beijing Aosaikang Pharmaceutical | 12.92B |
| PharmaBlock Sciences (Nanjing) | 12.76B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.75B |
| Zhejiang Medicine | 12.71B |
| Porton Pharma Solutions | 12.12B |
| Zhejiang CONBA Pharmaceutical | 11.87B |